Open Insider Trading Activity for United Therapeutics Corp Chairperson & CEO Rothblatt Martine A
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10b5-1: Scheduled Form 4 Transaction UTHR | 2026-10-22 | 2026-10-21 | United Therapeutics Corp | Rothblatt Martine A | Chairperson & CEO | Sell | 14 | 9,500 | $560.07 | $5,320,680.75 | 2.84% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction UTHR | 2026-10-20 | 2026-10-19 | United Therapeutics Corp | Rothblatt Martine A | Chairperson & CEO | Sell | 19 | 9,500 | $543.32 | $5,161,575.77 | 2.84% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction UTHR | 2026-10-19 | 2026-10-16 | United Therapeutics Corp | Rothblatt Martine A | Chairperson & CEO | Sell | 13 | 9,500 | $534.66 | $5,079,274.86 | 2.84% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction UTHR | 2026-10-16 | 2026-10-15 | United Therapeutics Corp | Rothblatt Martine A | Chairperson & CEO | Sell | 12 | 9,500 | $546.65 | $5,193,199.71 | 2.84% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction UTHR | 2026-10-15 | 2026-10-14 | United Therapeutics Corp | Rothblatt Martine A | Chairperson & CEO | Sell | 16 | 9,500 | $539.99 | $5,129,873.02 | 2.84% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction UTHR | 2026-10-14 | 2026-10-13 | United Therapeutics Corp | Rothblatt Martine A | Chairperson & CEO | Sell | 10 | 9,500 | $545.52 | $5,182,414.18 | 2.84% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction UTHR | 2026-10-13 | 2026-10-12 | United Therapeutics Corp | Rothblatt Martine A | Chairperson & CEO | Sell | 7 | 9,500 | $550.70 | $5,231,666.41 | 2.84% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction UTHR | 2026-10-09 | 2026-10-08 | United Therapeutics Corp | Rothblatt Martine A | Chairperson & CEO | Sell | 16 | 9,500 | $534.31 | $5,075,918.83 | 2.84% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction UTHR | 2026-10-08 | 2026-10-07 | United Therapeutics Corp | Rothblatt Martine A | Chairperson & CEO | Sell | 14 | 9,500 | $548.95 | $5,215,015.15 | 2.84% | View Filing |